Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to test the acceptability, feasibility, and effectiveness of esTOCma in families and relatives of individuals with obsessive-compulsive disorder (OCD). Specifically, a randomized controlled trial with two conditions (experimental and control) has been carried out in a sample of families and relatives of individuals with obsessive-compulsive disorder to assess pre-post-intervention changes. Researchers will compare experimental and control group to see if after using the app there is: lower stigma, higher knowledge and understanding about OCD, higher intention to seek help, and higher self-esteem and lower obsessive-compulsive symptoms. and there are no changes in the control group. The experimental group received the intervention through the esTOCma app.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Universitat de València
Valencia, Spain
Start Date
April 4, 2022
Primary Completion Date
September 30, 2022
Completion Date
September 30, 2022
Last Updated
September 27, 2024
211
ACTUAL participants
esTOCma: an app to fight stigma associated with OCD
DEVICE
Lead Sponsor
University of Valencia
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions